SCHEMBL2292273

SCHEMBL2292273

O=Cc1ccccc1COc1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 4/20 0.40
TDP1 Q9NUW8 3/20 0.40
LMNA P02545 3/20 0.40
MEN1 O00255 2/20 0.40
THRB P10828 1/20 0.40
BLM P54132 1/20 0.40
CDK4 P11802 1/20 0.38
CCND1 P24385 1/20 0.38
USP2 O75604 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2293569 0.82 ALDH1A1 (0.40) ALDH1A1HTTSMN1; SMN2HPGDKMT2A
SCHEMBL28503323 0.80 ALDH1A1 (0.49) ALDH1A1HTTSMN1; SMN2HPGDKMT2A
SCHEMBL1539550 0.79 ALDH1A1 (0.43) ALDH1A1HTTSMN1; SMN2HPGDKMT2A
SCHEMBL1539474 0.78 CDK4 (0.50) ALDH1A1HTTSMN1; SMN2HPGDKMT2A
SCHEMBL2293283 0.78 ALDH1A1 (0.46) ALDH1A1HTTSMN1; SMN2HPGDKMT2A
SCHEMBL2293305 0.78 ALDH1A1 (0.56) ALDH1A1HTTSMN1; SMN2HPGDKMT2A
SCHEMBL1200712 0.77 SMN1; SMN2 (0.50) ALDH1A1HTTSMN1; SMN2HPGDKMT2A
SCHEMBL1539552 0.76 CDK4 (0.44) ALDH1A1HTTSMN1; SMN2HPGDKMT2A
SCHEMBL2287854 0.76 ALDH1A1 (0.40) ALDH1A1HTTSMN1; SMN2HPGDKMT2A
SCHEMBL28510243 0.75 RAB9A (0.42) ALDH1A1HTTSMN1; SMN2HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994367-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-09 US disclosed
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-19 US disclosed
EP-2149545-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, C9, TRPA1 ALDH1A1 83/4885HTT 1687/4885SMN1; SMN2 3093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.